Heterozygous DDX41 LOF, however, is not sufficient to initiate leukemogenesis, and the majority of AML and MDS patients with germline variants carry additional somatic nonsynonymous substitutions primarily in the helicase catalytic center of the other allele. This evidence concerns the gene DDX41 and myelodysplastic syndrome.